Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription-polymerase chain reaction

被引:56
作者
Nieuwenhuis, EJC
Leemans, CR
Kummer, A
Denkers, F
Snow, GB
Brakenhoff, RH
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Otolaryngol Head & Neck Surg, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands
关键词
D O I
10.1097/01.LAB.0000083532.46536.56
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The presence of lymph node metastases is the major determinant for prognosis in head and neck squamous cell carcinoma (HNSCC). It is at present unknown whether the same holds true for the presence of histologically undetectable micrometastases. We analyzed 456 histologically tumor-negative lymph nodes of 23 HNSCC patients without (pN0) and 18 patients with one or two tumor-positive lymph nodes (pN+) in their neck dissection specimens at histopathologic examination. To detect the presence of disseminated tumor cells and micrometastases in these lymph nodes, we used real-time quantitative RT-PCR with E48 (Ly-6D) transcripts as a squamous cell-specific molecular marker. The results were compared with histopathologic examination and clinical outcome. E48 transcripts were detected in lymph nodes of 5 (22%) of 23 patients in the pN0 group, and in histologically negative lymph nodes of 10 (56%) of 18 patients in the pN+ group. In the pN0 group, the presence of E48-positive lymph nodes was significantly associated with a distinctly poor cause-specific survival as compared with those with E48-negative lymph nodes. Our results indicate that E48 real-time quantitative RT-PCR is a suitable method for the detection of micrometastases in lymph nodes of patients with HNSCC. Moreover, detection of micrometastases seems clinically relevant but should be confirmed in a large multicenter trial.
引用
收藏
页码:1233 / 1240
页数:8
相关论文
共 31 条
[1]   Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients [J].
Bostick, PJ ;
Morton, DL ;
Turner, RR ;
Huynh, KT ;
Wang, HJ ;
Elashoff, R ;
Essner, R ;
Hoon, DSB .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) :3238-3244
[2]  
Brakenhoff RH, 1999, CLIN CANCER RES, V5, P725
[3]   MOLECULAR ASSESSMENT OF HISTOPATHOLOGICAL STAGING IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].
BRENNAN, JA ;
MAO, L ;
HRUBAN, RH ;
BOYLE, JO ;
EBY, YJ ;
KOCH, WM ;
GOODMAN, SN ;
SIDRANSKY, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (07) :429-435
[4]  
Cortesina G, 2000, INT J CANCER, V89, P286, DOI 10.1002/1097-0215(20000520)89:3<286::AID-IJC12>3.0.CO
[5]  
2-U
[6]   Role of immunohistochemical detection of lymph-node metastases in management of breast cancer [J].
Cote, RJ ;
Peterson, HF ;
Chaiwun, B ;
Gelber, RD ;
Goldhirsch, A ;
Castiglione-Gertsch, M ;
Gusterson, B ;
Neville, AM .
LANCET, 1999, 354 (9182) :896-900
[7]   Minimal residual disease in head and neck cancer [J].
Gath, HJ ;
Brakenhoff, RH .
CANCER AND METASTASIS REVIEWS, 1999, 18 (01) :109-126
[8]  
Glickman JN, 1999, CANCER, V85, P769, DOI 10.1002/(SICI)1097-0142(19990215)85:4<769::AID-CNCR3>3.0.CO
[9]  
2-I
[10]  
Hosch S, 2000, CANCER RES, V60, P6836